BSX Filing
4Filing Date: May 21, 2026

BOSTON SCIENTIFIC CORP (BSX) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001225208-26-005548open_in_new
Total Value$100.0K
Trades1
Insiders1

Transaction Details

Pegus Cheryl
Director·Direct
Buy · Acquire
Common Stock
Shares+1.77K
Price$56.49
Total Value$100.0K
Shares Owned After1.77K
Transaction DateMay 20, 2026
Footnotes ▸

Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $56.49 to $56.5009, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Post-Transaction Holdings

Pegus Cheryl
SecuritySharesChange
Common Stock1.77K+1.77K
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-20 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BOSTON SCIENTIFIC CORP (BSX) CIK: 0000885725 --- Reporting Owner --- Name: Pegus Cheryl CIK: 0001572448 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-20 | Code: P (Open market purchase) Shares: +1,770 | Price: $56.49 Total Value: $99,987.30 Shares Owned After: 1,770 | Ownership: D (Direct) Footnotes: [F1] Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $56.49 to $56.5009, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. --- Footnotes (Complete Index) --- F1: Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $56.49 to $56.5009, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. --- Signature --- /s/ /s/ Susan Thompson, Attorney-in-Fact (2026-05-21)

keid AI analysis is for reference only and does not constitute investment advice.